The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/14828
StudyName: Eligibility Breast Neoplasms NCT00036270
Date of export from the portal: 02.07.2020
Date of Upload / last change: 01.05.2016
License: Creative Commons BY 4.0

----

Description: 
Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane; ODM derived from: https://clinicaltrials.gov/show/NCT00036270
